Pharma VC Funds

Main Sequence Ventures, founded in 2017 and backed by Australia's national science agency CSIRO, is a venture capital firm that focuses on deep tech and frontier technologies. The firm is headquartered in Australia and aims to solve significant global challenges through its investments. Main Sequence has a unique "venture science" model, which starts by identifying big challenges and bringing together science, people, and investment to create and fund companies that can address these issues. Main Sequence Ventures has built a strong portfolio with notable companies such as Q-CTRL, which makes quantum technology useful; Gilmour Space, which focuses on efficient satellite launches; and Emesent, a leader in robotics and autonomy technology. Other significant investments include Myriota, which provides low-cost satellite connectivity, and V2food, which develops sustainable meat alternatives. The firm's second fund, which raised $250 million, focuses on areas such as decarbonization, healthcare, and space technology. This fund supports companies like Kasada, a cybersecurity firm stopping bot attacks, and RapidAIM, which offers biosecurity solutions for pest management. Main Sequence Ventures is dedicated to leveraging scientific discoveries to create impactful, high-growth companies that can address some of the world's most pressing challenges. Their strategic investment approach and strong support for portfolio companies highlight their commitment to driving innovation and technological advancement globally.

Majycc Capital is a prominent French venture capital firm that focuses on revolutionizing the healthcare sector through strategic investments in innovative startups. Established in 2022 through the merger of Majycc eSanté Invest and UI Investissement, the firm now manages over €700 million, primarily dedicated to eHealth, MedTech, and BioTech ventures. Majycc Capital is particularly active in the Series A and B funding stages, where it seeks out high-potential startups across France and Europe that are positioned to deliver transformative advancements in healthcare. The firm's investment strategy goes beyond financial support. Leveraging its deep connections within the healthcare ecosystem, Majycc Capital provides comprehensive strategic assistance to its portfolio companies. This includes guidance on navigating complex regulatory pathways, insights into market dynamics, and support in business development—key elements that are crucial for scaling healthcare innovations. Majycc’s extensive network within the healthcare industry, including partnerships with healthcare manufacturers and private clinic groups, further amplifies the growth potential of the startups it backs. Majycc Capital’s commitment to innovation is underscored by its regional presence, with 13 offices throughout France, ensuring that it remains closely involved with local economies and emerging companies. The firm’s dedicated team, led by experienced professionals, is deeply invested in the success of its portfolio companies, working tirelessly to ensure they achieve their full potential in the competitive healthcare market​.

Maki.vc is a seed-stage venture capital firm that partners with deep tech and brand-driven startups focused on challenging category norms. Founded in 2018, Maki.vc invests in early-stage companies from their inception to Series A, emphasizing scientific advancements and unique customer understanding. Maki.vc has a global mandate, with a strong presence in the Nordics. The firm’s portfolio includes companies across various sectors such as AI, quantum computing, and sustainability. Notable investments include IQM, a leader in quantum computing; Spinnova, which develops sustainable textiles; and Onego Bio, which creates animal-free egg protein using novel technology. The firm’s approach goes beyond providing capital. Maki.vc supports its portfolio companies through Maki House, a platform that offers strategic guidance and a network of experts to help startups scale and achieve long-term success. Their investment philosophy centers on future-proofing companies by integrating ESG principles into their operations from the start, ensuring sustainability and long-term profitability.

Mandi Ventures is an early-stage venture capital fund based in São Paulo, Brazil, with additional offices in Brussels. The fund focuses on investing in disruptive technologies within the food, agriculture, and climate tech sectors. Mandi Ventures primarily targets startups involved in novel foods, biotech, life sciences, robotics, and precision farming, aiming to reshape how we produce and consume food. Their global investment reach includes startups across the Americas, Europe, and Israel. Mandi Ventures supports seed-stage companies, offering not just capital but also strategic business expertise to help startups commercialize their innovations. They focus on areas like supply chain logistics, wellness, sustainability, and SaaS platforms within the food and agriculture ecosystem. Notable investments include companies driving innovation in biotech and precision farming, ensuring that the fund stays at the forefront of transformative food technologies. With a strong network and industry connections, Mandi Ventures plays an active role in guiding its portfolio companies through their growth stages, from scaling operations to market expansion.

Mangrove Capital Partners is a dynamic venture capital firm known for its bold, patient approach and commitment to supporting innovative entrepreneurs globally. The firm, headquartered in Luxembourg, has a strong presence in Europe with offices in Berlin, Paris, Barcelona, and London, as well as in Tel Aviv, Israel. Mangrove has a proven track record of backing successful companies, having been early investors in five unicorns: Skype, Wix, WalkMe, K Health, and TBOL. Mangrove's investment strategy focuses on early-stage tech startups, often partnering with entrepreneurs even before their product launch. They are particularly interested in transformational ideas across various sectors, including fintech, e-commerce, and health tech. Some of their rising stars include Red Points, Adverity, and Flo Health. The firm is known for its hands-on support, offering not just capital but also strategic guidance and operational assistance. Mangrove's team, comprising experienced entrepreneurs and operators, works closely with startups to navigate the challenges of scaling and growth. This approach is reinforced by their reputation for being more than just investors—they are seen as anchor partners deeply involved in their portfolio companies' success.

Manta Ray Ventures is an early-stage venture capital firm based in London, founded by Sebastian Kulczyk. The firm focuses on backing mission-driven founders who aim to address significant global challenges using advanced technologies. Manta Ray Ventures provides flexible and patient capital, leveraging their resources and networks to support their portfolio companies. Their diverse portfolio includes notable investments such as Volocopter, a manufacturer of electric copters for urban mobility; Astranis, a developer of satellite-based communication services; and Bluu Biosciences, focused on food and agriculture technology. They also have investments in companies like Epic Games, the creator of the popular game Fortnite, and Juvena Therapeutics, which is involved in drug discovery and clinical trials. Manta Ray Ventures has achieved significant exits, including the acquisition of Frontier Car Group by OLX Group and the merger of Forge Platform. The firm has also seen one of its portfolio companies, Bridge, go public on the Tokyo Stock Exchange. Led by a team of experienced professionals, including Managing Partner Lawrence Barclay and Partner Leah von Siemens, Manta Ray Ventures is dedicated to fostering innovation and supporting the growth of transformative technologies across various industries.

March Capital, established in 2014 and based in Santa Monica, California, is a venture growth firm focused on next-generation technology companies. The firm emphasizes sectors such as enterprise AI, fintech, and commerce enablement, aiming to partner with visionary entrepreneurs and support their growth to market leadership. Notable investments in March Capital's portfolio include CrowdStrike, a leader in cybersecurity; BillDesk, India's premier payments network; and Canva, an online design platform. They have also invested in companies like ActionIQ, a customer data platform, and ASAPP, an AI software company automating customer service. March Capital has seen successful exits from companies such as CarTrade, an online automotive marketplace, and Forescout, a cybersecurity firm. The firm is known for its collaborative approach, working closely with portfolio companies to provide strategic guidance and leveraging their extensive network to drive growth and success. They focus on building concentrated portfolios and doubling down on high-potential investments, ensuring significant impact and returns. March Capital also hosts The Montgomery Summit, a premier technology conference that gathers leading entrepreneurs, investors, and corporate executives to foster relationships and catalyze growth for portfolio companies.

MarsBio is a Los Angeles-based venture capital fund that focuses on investing in pre-seed and seed-stage biotech startups. The firm specializes in biosciences and frontier technologies, targeting innovations in healthcare, therapeutics, synthetic biology, and the future of food. With check sizes ranging from $250K to $500K, MarsBio supports startups that push the boundaries of biology, using it as a tool for manufacturing and sustainable solutions. Their portfolio reflects an interest in companies working on immunology, oncology, neuroscience, and bio-enabling technologies, such as research tools and bioelectronics. Co-founded by Rob Rhinehart, best known for creating Soylent, MarsBio aims to back visionary founders with disruptive ideas. The firm emphasizes its support for entrepreneurs tackling complex problems, particularly those related to sustainable food supply chains and novel healthcare solutions. MarsBio’s strategy is to engage deeply with founders at the earliest stages, helping them scale innovative solutions that have the potential to redefine industries. MarsBio primarily invests in U.S.-based companies and leverages its expertise and network to drive transformational progress in biosciences. They’re especially drawn to startups that are pioneering new technologies that could shape the next era of healthcare and sustainable living.

Martlet Capital is an early-stage venture capital firm based in Cambridge, UK, focused on deep technology and life sciences B2B startups. Since its inception in 2011, Martlet Capital has invested in over 70 companies, providing patient capital to high-growth potential ventures. Their portfolio spans sectors like artificial intelligence, digital health, personalized medicine, engineering, IoT, new materials, and quantum technologies. Notable investments include Echion Technologies, known for their superfast-charging lithium-ion batteries, and IESO Digital Health, which provides real-time cognitive behavioral therapy online. They have also invested in companies like Converge, developing wireless sensor networks for real-time construction monitoring, and Dogtooth Technologies, which creates autonomous robots for productivity enhancement. Martlet Capital typically leads funding rounds and supports its portfolio companies beyond capital with strategic guidance, network access, and operational expertise. Their successful exits include Arachnys, Audio Analytic, and Cambridge CMOS Sensors. Martlet Capital's team comprises experienced investors and entrepreneurs, who actively engage in nurturing startups from early commercialization stages to scaling. Their investment strategy focuses on fostering innovation and driving growth in the UK, particularly within the Cambridge tech ecosystem. For startups seeking investment, Martlet Capital looks for innovative solutions with scalable business models in deep tech and life sciences. They prioritize strong leadership teams and groundbreaking technologies that can make a significant impact on their respective industries.

MassMutual Ventures (MMV) is a global venture capital firm that invests in a range of sectors, including enterprise software, cybersecurity, financial technology, digital health, and climate technology. Founded in 2014 and based in Boston, MMV also has offices in London and Singapore. The firm manages over $1 billion in investment capital and focuses on accelerating the growth of its portfolio companies by providing capital, connections, and strategic advice. Notable investments by MMV include Prove, a leader in digital identity solutions; Daye, a gynecological health startup; and Griffin, a developer-friendly Banking as a Service platform. The firm's portfolio spans across various stages of investment, from seed to growth stage, with typical check sizes ranging from $100,000 to $5 million. In 2022, MMV launched a $100 million Climate Technology Fund to invest in early and growth-stage companies addressing climate change. This fund aims to support 15 to 20 companies developing solutions to mitigate, measure, and manage climate change impacts, further expanding MMV's commitment to sustainable innovation​. The team at MMV includes experienced investors, former entrepreneurs, and operators, such as Doug Russell, the Managing Partner and Head of MMV, and Ryan Collins, the Managing Partner for Europe and APAC. Their deep industry expertise and extensive network help portfolio companies scale and succeed in competitive markets.

MassVentures, established in 1978 as the Massachusetts Technology Development Corporation, is a venture capital firm dedicated to supporting early-stage technology startups in Massachusetts. With a mission to bridge the capital gap for startups, MassVentures has invested $91.9 million in 152 companies from its inception through June 2019. The firm focuses on diverse sectors including life sciences, robotics, and advanced manufacturing, and typically makes initial investments of $250,000 to $500,000. Notable investments include Battery Resourcers, Inkbit, and Pison. Additionally, MassVentures administers the Small Business Innovation Research Targeted Technologies (SBIR-TT) grant program, which has awarded $22.1 million to 79 companies since 2012. This program supports the commercialization of innovations emerging from academic research and small businesses, fostering technological advancement and job creation in the state. MassVentures is led by an 11-member board of directors, predominantly from the private sector, and operates with a small team based in Boston. The firm not only provides financial support but also strategic guidance and operational expertise to help startups scale successfully. Through its investments and grant programs, MassVentures plays a crucial role in the growth of Massachusetts' innovation ecosystem, aiming to enhance the state's economic development by nurturing high-potential startups.

Material Impact, founded in 2015 by Adam Sharkawy and Carmichael Roberts, is a venture capital firm based in Boston, Massachusetts, that focuses on transforming material science innovations into impactful real-world applications. The firm is dedicated to addressing large-scale problems related to food, water, sustainable manufacturing, transportation, mobility, and healthcare through its investments in deep tech companies. Material Impact's portfolio includes notable companies such as DetraPel, Bloomer Tech, Folio Photonics, and Nohbo. These investments span a range of industries, including specialty chemicals, healthcare monitoring equipment, IT storage, and personal products. The firm’s hands-on approach to building companies involves working closely with founders to guide them through critical growth stages​. In 2023, Material Impact announced its $352 million Fund III, aimed at continuing its mission to support early-stage startups that leverage material science to solve pressing global challenges. This new fund allows Material Impact to take larger ownership stakes while maintaining its active role in company development. The firm's commitment to diversity and impact is reflected in its alignment with the United Nations Sustainable Development Goals and its diverse leadership team​. For entrepreneurs interested in partnering with Material Impact, the firm values innovations that have strong scientific foundations and the potential to address significant human needs. Material Impact provides not only capital but also strategic and operational support, often embedding its team members within portfolio companies to ensure their success.

Math Venture Partners, founded in 2014 and based in Chicago, Illinois, is an early to middle-stage venture capital firm that focuses on investing in digital and technical companies. The firm emphasizes supporting entrepreneurial teams with a strong focus on customer acquisition and operational efficiency, leveraging their extensive experience as operators who have built, scaled, and sold businesses valued at over $7 billion. The firm has a diverse portfolio across various sectors, including SaaS, marketplace businesses, and tech-enabled services. Notable investments include Acorns, a wealth-building platform; Built In, a national recruiting platform for technical and sales talent; Chowly, which helps restaurants manage their menus and connectivity to third-party tech; and NoRedInk, an e-learning platform that improves students' grammar and writing skills. Math Venture Partners is managed by seasoned investors and operators, including Managing Directors Mark Achler, Troy Henikoff, and Dana Wright. They have partnered with over 200 companies, focusing on providing both capital and strategic support to help them grow with greater certainty. Despite their success, the firm announced that they will not raise a third fund, citing the challenging fundraising environment and their commitment to fully supporting their current portfolio companies.

Matrix Partners is a powerhouse in early-stage venture capital, boasting over four decades of experience and $4 billion in assets under management. Their portfolio spans transformative startups like Canva, Afterpay, Oculus, and Hubspot, among 65+ IPOs and 110+ acquisitions. With offices in San Francisco and Boston, Matrix invests globally, focusing on the U.S., India, and China. Their sweet spot is in sectors like AI, fintech, digital health, and B2B SaaS. Matrix is known for its commitment to backing founders from seed through Series A, providing checks ranging from $100K to $1M. They emphasize patience, nurturing relationships with company builders and former founders, helping them scale effectively. While they often lead rounds, Matrix also co-invests, partnering with top VCs like Y Combinator and Andreessen Horowitz. Key team members include Pranay Desai and Paul Sherer in San Francisco, and they maintain a reputation for being hands-on, leveraging deep expertise across diverse tech-driven industries. Entrepreneurs seeking funding should approach Matrix with a clear vision for scalable innovation, as the firm is laser-focused on high-impact, technology-driven ventures.

Matterwave Ventures, established in early 2022 from the former btov Industrial Technologies team, focuses on investing in early-stage European industrial hardware and software companies. Headquartered in Munich, Germany, Matterwave aims to empower startups to become global leaders in the industrial sector. Their €130M Matterwave Industrial Technologies II fund backs 20-25 companies, with initial investments ranging from €1M-4M and up to €10M in follow-on rounds. Matterwave's investment strategy prioritizes automation, digitalization, and resource efficiency within industrial value chains. They target technologies in enterprise automation, frontier tech, production optimization, and sensor-powered solutions. Notable portfolio companies include TVARIT, which specializes in AI for sustainable manufacturing, and Orcan Energy, focusing on industrial heat capture. Led by a team with over 50 years of combined venture capital experience, Matterwave Ventures leverages deep industry knowledge and strong market connections to support its portfolio companies. The team includes experts with backgrounds in engineering, physics, and technology commercialization, ensuring they provide comprehensive strategic guidance. Matterwave Ventures emphasizes sustainability and resource efficiency, aligning their investments with the EU's Sustainable Finance Disclosure Regulation. This commitment reflects their broader goal of enhancing Europe's industrial competitiveness while addressing environmental challenges​.

Maven Ventures is a seed-stage venture capital firm specializing in consumer software startups. With a notable track record, Maven has backed major successes like Zoom, Cruise, and Epic!, achieving significant exits and IPOs. Founded in 2013, the firm has maintained a focused strategy, supporting around 50 high-potential startups with investments typically ranging from $750K to $1M. The firm is keenly interested in emerging consumer trends and technologies, investing in sectors like digital health, autonomous vehicles, fintech, and AI-driven solutions. Geographic focus primarily includes the United States, particularly Silicon Valley, but Maven also invests in global opportunities. Maven Ventures' strategy is highly selective, with a small team providing hands-on support to a concentrated portfolio. The team, led by seasoned investors like Jim Scheinman, focuses on building deep relationships with founders, offering critical guidance on marketing, product development, and go-to-market strategies. Recent investments include startups like Hello Heart, which provides mobile solutions for heart health, and Wildtype, a company pioneering lab-grown seafood. The firm has a proactive approach to diversity, supporting a range of women-led and minority-led startups. Maven Ventures prefers to be approached through a well-articulated pitch that demonstrates a strong market need and scalable solution. With a reputation for nurturing bold founders and transformative ideas, Maven Ventures remains a prominent player in the VC landscape, consistently driving innovation and impactful growth in the consumer tech sector​.

Maverick Ventures, established in 2015, is the venture capital arm of Maverick Capital, a multi-billion dollar investment firm. Based in San Francisco, Maverick Ventures focuses on early-stage and growth-stage investments, particularly in healthcare and technology sectors. The firm prides itself on combining the agility of a focused venture team with the extensive resources and reputation of a global investment firm. Maverick Ventures has built a diverse portfolio that includes notable companies such as Cityblock Health, Devoted Health, Collective Health, and Databricks. They typically support startups through seed to maturity stages, providing not just capital but also strategic guidance and operational support. The team at Maverick Ventures includes experienced investors like Lee Ainslie, who bring a wealth of expertise to their investments. The firm operates with an evergreen fund structure, allowing them to reinvest profits and continuously support their portfolio companies.

Maveron, a consumer-only venture capital firm, was founded in 1998 by Dan Levitan and Howard Schultz, the visionary behind Starbucks. The firm focuses on early-stage investments in transformative consumer brands. With a keen understanding of consumer behavior and market trends, Maveron has built a diverse portfolio that includes notable companies like Allbirds, Everlane, and Zulily. Maveron operates with a mission to back entrepreneurs who aim to change how people live, work, learn, play, eat, and stay well. Their investments span various consumer sectors such as health and wellness, e-commerce, and food innovation. Some of their prominent exits include eBay, Trupanion, and Potbelly Sandwich Works. The firm recently raised $225 million for its eighth fund, continuing its legacy of identifying and supporting early-stage consumer startups. Maveron's team, led by experienced partners like Dan Levitan and Jason Stoffer, brings deep industry knowledge and a commitment to fostering long-term partnerships with entrepreneurs.

Max Ventures, founded in 2013 by Ryan Darnell and Sophie Stenbeck, is a dynamic seed-stage venture capital firm based in New York. Notable for its early investments in companies like Boxed, ZoomCar, Button, and Drone Racing League, Max Ventures focuses on consumer tech and health-tech startups. The fund targets North American markets and emphasizes investing in founders with unique consumer insights and relentless drive. Max Ventures typically makes initial investments ranging from $750K to $1M, often leading the rounds. Their strategy involves a hands-on approach, leveraging their extensive network to support portfolio companies in achieving significant growth. The fund is particularly interested in startups within the fashion/beauty, food and beverage, internet and web services, real estate, and software industries. The team, including key figures like Managing Partner Matthew Weinberg, prides itself on its ability to identify and nurture innovative talent. Startups looking to approach Max Ventures should focus on demonstrating strong consumer insight and a clear execution plan. Recently, the firm has been active with investments like UnityAI in healthcare technology, showcasing their ongoing commitment to pioneering advancements in tech.

Mayfield is a renowned venture capital firm founded in 1969, with a focus on early-stage investments. The firm is based in Menlo Park, California, and has a strong presence in the U.S. and India. Mayfield has made significant contributions to the tech industry, backing over 852 companies, including notable names like Lyft, Couchbase, and Poshmark. Mayfield’s portfolio showcases a diverse range of sectors, emphasizing artificial intelligence, enterprise software, consumer tech, semiconductors, and human and planetary health. Some of their standout investments include Unstoppable Domains, Amagi, and BigPanda, which have grown into unicorns under their guidance. The firm has also successfully shepherded companies to IPO, such as Lyft and Couchbase, and facilitated numerous high-profile acquisitions. The firm operates with a "people-first" investment philosophy, aiming to partner with visionary entrepreneurs from inception through growth stages. They typically invest in Seed, Series A, and Series B rounds, providing not only capital but also strategic support and mentorship. Mayfield's investment team includes seasoned partners like Navin Chaddha and Ursheet Parikh, who bring extensive industry experience and a track record of successful exits. Mayfield's investment strategy involves close collaboration with founders, focusing on building enduring companies that can achieve market leadership. Founders looking to connect with Mayfield should highlight their innovative solutions and potential for significant impact, aligning with the firm’s mission to back transformative technologies.

MBX Capital, established in 2015, is a venture capital firm headquartered in Claymont, Delaware. The firm specializes in early-stage investments within the healthcare and life sciences sectors, focusing on pre-seed, seed, and Series A rounds. MBX Capital has a robust portfolio that includes companies like Luna, Concert Health, Koneksa Health, Atlas Labs, and Buoy Health​. Notable recent investments by MBX Capital include Vivodyne, which raised $38 million in November 2023, and Macro Trials, which secured $6 million in June 2023. These investments underline the firm's commitment to advancing biotechnology and clinical trials​ (PitchBook)​. Additionally, MBX Capital led a $10.7 million Series A financing for Contraline, supporting the development of innovative medical technologies​​. The firm's co-founders, Gurdane Bhutani and Zeshan Muhammedi, lead a team that provides hands-on support to portfolio companies, leveraging their expertise and extensive network to drive growth and innovation​​. MBX Capital's strategic approach and active involvement make it a key player in the venture capital landscape for healthcare and life sciences startups.

Medicxi is a premier European venture capital firm specializing in life sciences, with a focus on drug discovery and therapeutic development. Established in 2016 by the former life sciences team of Index Ventures, the firm has raised over €1 billion across various funds. Medicxi’s flagship funds, such as Medicxi III (€400 million), invest in both early and late-stage biopharma companies. Notable investments include Genmab, Micromet (acquired by Amgen), and Minerva Neurosciences. Medicxi's investment strategy is centered around its "asset-centric" approach, where the firm invests in companies with strong clinical proof-of-concept that address clear unmet medical needs. Their investments typically range between €10 million and €25 million, supporting companies through key phases like clinical development and regulatory approval​. The firm partners closely with major pharmaceutical players such as Novartis, Johnson & Johnson, and GlaxoSmithKline, which provides strategic backing for its portfolio companies​. Headquartered in London, Geneva, and Jersey, Medicxi has become a leading name in European biotech, with a strong emphasis on translating scientific innovation into commercially viable drugs. Their portfolio spans across the full healthcare continuum, from early discovery to late-stage clinical assets, giving them a unique position in Europe’s life sciences ecosystem. Through its deep ties to industry leaders and a robust scientific advisory board, Medicxi continues to drive the next generation of breakthrough therapeutics​.

Manifold Ventures (MMV) is a venture capital firm focused on supporting early-stage companies in healthcare innovation. Founded by physicians and healthcare entrepreneurs, MMV invests in startups that are developing groundbreaking medical technologies and solutions. The firm is known for its hands-on approach, offering more than just capital; they provide strategic guidance, operational expertise, and access to an extensive network of industry professionals. Their portfolio includes companies like Stellation (patient-provider matching technology), PocketRN (telehealth nursing), and Gradient Health (a healthcare data marketplace). MMV's team, led by Dr. Branden Rosenhan and Dr. Saumitra Thakur, brings deep experience in both clinical practice and business, which they leverage to help their portfolio companies navigate the complexities of the healthcare industry. MMV is headquartered in Salt Lake City and focuses on identifying promising healthcare innovations early in their development cycle, with the goal of helping these startups scale into successful enterprises.

MedVenture Partners, Inc., a Tokyo-based venture capital firm, specializes in early-stage investments within the life sciences sector, with a distinct focus on medical devices and healthcare technologies. Established in 2013 by Hajime Oshita and Dr. Fumiaki Ikeno, the firm has rapidly built a reputation for identifying and nurturing innovative startups poised to disrupt the healthcare landscape. Their portfolio includes standout companies such as Biomedical Solutions, Inc., which exemplifies their commitment to fostering groundbreaking technologies. MedVenture’s investment strategy is characterized by a hands-on approach, often leading funding rounds and providing substantial guidance to portfolio companies. They prioritize startups that demonstrate strong potential for global impact, particularly those addressing critical medical needs. Their geographic focus remains largely on Japan, but they have shown interest in companies that can expand internationally. With over 22 billion Yen in assets under management, MedVenture manages multiple funds, the most recent of which raised 99 billion Yen. The firm’s approach to investment is strategic and collaborative, leveraging deep medical expertise alongside innovative technology. Startups seeking investment should be prepared to present compelling, well-researched pitches that highlight their innovation and market potential. Led by a team of seasoned professionals, including Oshita, who has over two decades of experience in the medical device industry, MedVenture Partners is committed to driving successful exits and significant market advances. Their active involvement in the growth and development of their portfolio companies underscores their role as a key player in Japan’s venture capital landscape.

Menlo Ventures, a Silicon Valley-based venture capital firm, has a robust history of investing in transformative technology companies across consumer, enterprise, and healthcare sectors. Notable investments include Uber, Roku, Warby Parker, Poshmark, and Chime. The firm focuses on early-stage investments but supports companies through their entire growth journey. Menlo Ventures recently closed a $1.35 billion fund aimed at backing the next generation of AI startups, reflecting its commitment to cutting-edge technologies. The firm also emphasizes deep involvement with portfolio companies, offering strategic guidance and support through every stage of development.

Meridian Street Capital is a venture capital firm established in 2016, based in New York City. The firm specializes in early-stage investments at the intersection of healthcare and technology. Their approach is to support founders from the earliest stages, often from day one, to help turn innovative ideas into category-defining companies. Meridian Street Capital has a strong portfolio that includes companies like 1upHealth, ClosedLoop.ai, and Jona Health, among others. They focus on investing in businesses that leverage technology to improve healthcare services, access, and efficiency. Typically, their investments range from $100K to $5M, with a sweet spot around $1.5M. The firm has a hands-on approach, providing strategic guidance and leveraging their industry connections to support the growth of their portfolio companies. The team at Meridian Street Capital includes key figures such as George Ribaroff and T. Scott Law Jr., who bring extensive experience in venture capital and healthcare technology. They have a focused strategy, partnering with a concentrated group of startups to ensure dedicated support and resources. Meridian Street Capital has made a total of 47 investments and has seen several successful exits, including Valify and Hint Health. Their investment strategy emphasizes backing exceptional teams with innovative solutions that have the potential to transform healthcare.

Metaplanet Holdings, founded in 2011 by Jaan Tallinn, co-founder of Skype, is a venture capital firm based in Tallinn, Estonia. The firm focuses on early-stage investments in deep technology startups that promise long-term societal and civilizational impacts. Metaplanet emphasizes funding science-heavy projects and non-commercial research aimed at reducing existential risks, particularly from AI and other advanced technologies. Metaplanet has a diversified portfolio of over 150 startups, with notable investments including BillionToOne, a provider of cell-free cancer liquid biopsy tests, and Anthropic, an AI-based conversational chatbot service. The firm has made more than 50 successful exits, including companies like Ampler Bikes and Apprente. Recent investments include $7 million in the blockchain company Fhenix and $13 million in Neurable, a brain-computer interface technology company. The firm's investment strategy focuses on sectors such as AI, neuroscience, blockchain, and encryption, supporting innovations that have the potential to disrupt industries or create entirely new ones. Metaplanet's team, led by Managing Partner Rauno Miljand and Partner Alexey Morgunov, operates with a lean structure, enabling them to make impactful and strategic investments.

Metavallon VC, founded in 2018 and based in Athens, Greece, focuses on early-stage investments in technology startups, particularly those connected to Greece. They typically invest in seed and pre-seed stages, with initial funding tickets ranging from €500K to €1.5M. The firm emphasizes supporting startups in sectors like transportation and mobility, energy and cleantech, space and aviation, machine learning and AI, and more. Notable investments by Metavallon VC include Ferryhopper, a leading ferry booking platform, and Wikifarmer, which aims to democratize agricultural commerce. The firm has also successfully exited from companies such as Seervision, which specializes in AI-driven camera automation software, and Think Silicon, a provider of graphics technology solutions. Metavallon VC offers extensive support to their portfolio companies, including business development, B2B sales, recruiting, and exit planning. Their approach combines financial backing with hands-on guidance to help startups scale and achieve significant market impact. The leadership team includes George Karantonis, Myrto Papathanou, and Yorgos Mousmoulas, who bring extensive experience in venture capital and technology investments.

Metrodora Ventures is a New York-based venture capital firm founded in 2020 by Chelsea Clinton. The firm focuses on early-stage investments in the health and learning sectors, with a mission to support companies that improve access to care, education, and vital information. Metrodora Ventures is driven by a values-conscious approach, investing in purpose-driven startups that aim to make a significant impact on society. The firm’s portfolio includes innovative companies like Teal Health, which is developing telehealth platforms focused on women’s health, and Blooming Health, which creates technology to help older adults maintain connections with their communities. Another notable investment is Swing Therapeutics, which develops digital therapies for chronic illness management. Metrodora Ventures operates with the goal of nurturing its portfolio companies by providing capital, market insights, and industry relationships. The firm raised its debut fund of $20.8 million and is currently in the process of raising a second fund to continue its mission of fostering impactful startups.

Noshaq is an investment fund based in Liège, Belgium, that offers a range of financing solutions aimed at fostering the creation and growth of companies, particularly SMEs. Established in 1985 under the name Meusinvest, the organization has grown significantly and rebranded to Noshaq in 2019 to better reflect its innovative and dynamic approach to investment. Noshaq manages a portfolio of 477 companies and has supported over 1,020 companies since its inception. The fund's primary focus areas include biotechnology, industry 4.0, digital technology, quality food, real estate, energy, sustainable development, and cultural industries. They provide funding through various vehicles, including equity investments, loans, and leasing, tailored to the specific needs of each stage of a company's development. Notable initiatives under Noshaq include Noshaq Spin-Offs, which supports the creation of spin-offs in collaboration with the University of Liège, and LeanSquare, which focuses on innovative projects in cultural and creative industries, enterprise software, and life sciences. Additionally, Noshaq is actively involved in regional development projects, such as La Grand Poste, a creative hub in the heart of Liège.

MGV Capital Group is an early-stage venture capital firm focused on investing in tech startups across North America, Latin America, and Israel. The firm primarily targets sectors such as fintech, consumer internet, enterprise software, artificial intelligence, and machine learning. Headquartered in San Antonio, Texas, MGV leverages a global network and deep sales expertise to support founders in building scalable, go-to-market teams. Notable investments from MGV include Codiga, a software development lifecycle platform acquired by Datadog, and Plerk, a digital employee benefits startup in Mexico that recently merged with Minu to enhance its platform. Other significant investments include Med247 in Vietnam, FishLog in Indonesia, and Giztix in Thailand. MGV’s strategy involves leading seed and early-stage funding rounds, offering not just capital but also strategic guidance and extensive support through their network. They aim to back a limited number of high-potential startups each year to provide focused, hands-on mentorship and resources. The team, led by co-founder and managing partner Marc Schröder, brings a wealth of experience from both entrepreneurial and investment backgrounds. For startups looking to engage with MGV, it's crucial to showcase innovative solutions with strong market potential and scalability, particularly in the targeted tech sectors.

MHS Capital, founded in 2006 and based in San Francisco, California, focuses on early-stage investments in technology-driven companies. They have a diverse portfolio, investing across sectors such as software, e-commerce, mobile, and healthcare. Notable investments include companies like Zenput, a business productivity software, and Grove Collaborative, an eco-friendly consumer goods company. MHS Capital has made a total of 102 investments, with 48 successful exits, including companies like Udemy and Thumbtack. The firm emphasizes close collaboration with visionary founders to build the next generation of category-defining companies.

Micron Ventures, the venture capital arm of Micron Technology, focuses on early-stage investments in deep tech startups, particularly those working on AI, machine learning, and innovative hardware solutions. With two dedicated funds—totaling $300 million—the firm aims to accelerate innovations that can transform compute infrastructure and AI-driven applications. Fund II, launched with $200 million, emphasizes deep tech innovations and earmarks 20% of its capital for startups led by women and underrepresented groups. Micron Ventures has a track record of backing high-potential companies, contributing not only capital but also strategic support to help them scale globally. Some notable investments include Aqua Membranes, a clean-tech company focused on sustainable water solutions, and Iterative Scopes, a company leveraging AI to advance healthcare diagnostics. The firm’s portfolio also spans sectors like autonomous systems and cybersecurity, with key investments in SambaNova and Mythic AI. Micron Ventures integrates its investment strategy with its corporate goals, especially in sustainability and AI. By investing in companies at the intersection of hardware and software innovation, Micron Ventures helps push technological boundaries while also advancing Micron’s business objectives.

Middle East Venture Partners (MEVP) is one of the largest and most established venture capital firms in the Middle East, with a focus on investing in early and growth-stage technology startups across the GCC and Levant regions. Founded in 2010, MEVP manages over $300 million in assets and has invested in more than 60 startups, many of which operate in sectors such as fintech, e-commerce, mobility, SaaS, and healthtech. With offices in Dubai, Beirut, Bahrain, and Riyadh, MEVP targets innovative companies that have the potential to scale regionally and globally. Their portfolio includes successful companies like Anghami, the first legal music streaming platform in the Arab world to go public, Nana, a leading online grocery delivery service, and Bykea, a Pakistani super app offering transport and delivery services. MEVP offers both financial backing and strategic support to help these businesses grow, focusing on building sustainable, scalable models that align with local market needs. MEVP has also made significant exits, such as its partial exit from Fresha, a beauty and wellness platform, generating impressive returns. With its recent launch of the $150 million Middle East Venture Fund IV, MEVP continues to drive innovation by supporting digital services and tech-based solutions that address local challenges and tap into global trends​.

Middleland Capital, a venture capital firm founded in 2010 and based in Washington, D.C., focuses on innovative foodtech and agtech companies. With over $100 million invested and a portfolio of 25 direct investments, the firm supports high-growth companies that are looking to scale their de-risked technology and proven business models​. The firm's notable investments include AeroFarms, the largest indoor vertical farming company in the US; Soli Organic, a leading grower and marketer of fresh organic culinary herbs; and MycoTechnology, an ingredient company that utilizes proprietary processes to remove flavor defects in food products without chemicals or GMOs​​. Other significant investments include EarthOptics, which provides real-time soil data maps, and Farmwise, which develops systems to streamline farming operations and increase food production efficiency​. Middleland Capital has a strong track record of successful exits, such as Seventh Generation, which was acquired by Unilever, and Benson Hill, which went public on the NYSE. The firm continues to catalyze global change in food and health through its targeted investments in innovative technologies and sustainable solutions.

MIG AG, based in Munich, Germany, is a prominent venture capital firm investing primarily in deep tech and life sciences. Their notable portfolio includes BioNTech, renowned for its COVID-19 vaccine, and companies like German Bionic, developing exoskeletons, and iOmx Therapeutics, focusing on novel cancer treatments. With over €1.2 billion in committed capital, MIG AG targets early to mid-stage startups that drive technological advancements and societal benefits. Their strategy is to invest in companies with groundbreaking innovations in biopharmaceuticals, medical technology, digital health, advanced computing, and environmental tech. MIG AG is known for its rigorous due diligence and active involvement in portfolio companies, providing strategic support and leveraging an extensive network to foster growth. Key team members include co-founders Jürgen Kosch and Michael Motschmann, both based in Munich, who bring decades of experience in venture capital and entrepreneurship. Startups can approach MIG AG through direct contact or their extensive industry network, emphasizing innovative solutions with strong growth potential. For entrepreneurs seeking investment, MIG AG values clear, impactful pitches that demonstrate significant technological breakthroughs and market readiness.

Milltrust International Group is a specialist investment firm co-headquartered in London and Singapore, known for its focus on sustainable investment strategies. The firm manages assets across public and private markets, with a particular emphasis on addressing global challenges such as food security, climate change, and emerging economies. Their investment philosophy, termed "Sustainable Prosperity," integrates wealth creation with ethical, planet-friendly goals. Milltrust operates through several branches, including Milltrust Ventures, which focuses on venture capital investments in sectors like healthcare, technology, and sustainable agriculture. The firm also manages East West Private Wealth, a multi-family office dedicated to wealth management services that align with eco-conscious and transparent investment strategies. This diverse approach allows Milltrust to support both institutional investors and high-net-worth families globally. In recent years, Milltrust has invested in impactful projects such as sustainable agricultural land in Australia and New Zealand, and high-growth technology companies that promote environmental sustainability.

Mirae Asset Venture Investments is the venture capital arm of Mirae Asset Financial Group, a global financial services giant headquartered in South Korea. The venture fund focuses on early to growth-stage investments, particularly in the technology, life sciences, fintech, and consumer sectors. Their portfolio features prominent companies like Unacademy, Ola, Zomato, and Bigbasket, reflecting their strong interest in emerging markets and digital platforms. Geographically, the fund has a significant presence across Asia, particularly in India and Southeast Asia, as well as North America. Mirae Asset employs a long-term, research-driven investment strategy, often co-investing with other prominent VC firms like SIG Venture Capital and Peak XV Partners. They have been especially active in 2024, making several key investments across various sectors, including fintech startup Jupiter and online grocery platform HappyFresh. With a focus on strategic growth, they seek companies that can redefine industries or introduce innovative solutions, and provide not just capital but also robust portfolio management. Their team, led by key executives like Ashish Dave in India, supports portfolio companies with deep market insights and hands-on guidance​.

Miroma Ventures is the investment arm of The Miroma Group, focusing primarily on venture and growth-stage investments in consumer brands and media platforms. Based in London, the firm leverages the extensive marketing expertise and global network of The Miroma Group to accelerate the growth of its portfolio companies. This unique approach allows Miroma Ventures to offer a mix of capital investment and tailored marketing services, making them a strategic partner for companies looking to expand their reach and scale rapidly. Miroma Ventures typically invests in the Seed, Series A, and Series B stages, with investment sizes ranging from $250,000 to $5 million. The firm is known for its interest in sectors like food and beverage, beauty and personal care, e-commerce, and digital media. They also offer flexible financing solutions, such as media services in exchange for equity, combining both financial and marketing support. The company has backed over 50 brands globally, including well-known names like ClassPass and Pinterest, reflecting its strong track record in the consumer and media industries. Miroma Ventures is particularly interested in partnering with businesses that show strong growth potential and can leverage its marketing expertise to build long-term value. With its focus on purpose-driven investments and consumer engagement, Miroma Ventures continues to support innovative brands that connect with modern audiences while fostering substantial growth.

Mission Bay Capital is a venture capital firm based in San Francisco, focused on early-stage investments in the biosciences. Established in 2009, the firm aims to support innovative entrepreneurs addressing critical medical and environmental challenges. Their portfolio includes companies like Caribou Biosciences, Alector, Zymergen, and Mammoth Biosciences, which utilize cutting-edge technologies such as CRISPR for molecular diagnostics​​. The firm has recently raised its third fund, totaling $60 million, which will continue to invest broadly in biotechnology innovations. Mission Bay Capital operates MBC BioLabs, a life-science incubator that has helped launch 138 companies, raising over $3.5 billion in total. This incubator provides state-of-the-art equipment and services to early-stage biotech companies, enabling them to advance their research and development efficiently​. Mission Bay Capital is led by Douglas Crawford, Ph.D., along with a team of experienced professionals like Robert Blazej, Ph.D. They emphasize disciplined investing and a management culture rooted in respect and inclusion, aiming to deliver superior returns and strategic opportunities to their limited partners​.

Mission BioCapital, founded in 2009, is a venture capital firm that focuses on early-stage investments in life sciences companies. With offices in Cambridge, Massachusetts, and San Francisco, California, the firm supports startups from the idea phase through to key development milestones. Mission BioCapital emphasizes collaboration and innovation, providing capital and strategic support to help scientific solutions reach the clinic faster and more efficiently. The firm recently announced raising $275 million for its fifth fund, Mission BioCapital V, which is aimed at funding transformative startups in therapeutics, diagnostics, medical devices, laboratory tools, and drug delivery. This fund also emphasizes company creation, working with academic researchers and entrepreneurs to launch startups based on novel technologies. Notable portfolio companies include Caribou Biosciences, Effector Therapeutics, and Alector, with several successful exits and IPOs. Mission BioCapital has also co-founded companies like ARase Therapeutics, Arclight Therapeutics LLC, Jupiter Bioventures, and Telo Therapeutics, demonstrating its deep involvement in nurturing groundbreaking life science ventures. The team at Mission BioCapital includes experienced professionals like Dr. Michael D. Taylor, who has a significant background in drug development at Pfizer and startups like Deciphera Pharmaceuticals. Co-Managing Partner Steve Tregay also brings extensive experience from his tenure at FORMA Therapeutics and the Novartis Venture Fund.

MissionPoint Partners, established in 2006, is a leading impact investment firm focused on addressing large-scale environmental and social challenges. By mobilizing high-impact capital, the firm collaborates with families, foundations, and institutions to drive both financial returns and measurable social change. With expertise in climate tech, sustainability, and renewable energy, MissionPoint Partners has built a reputation for backing companies that generate meaningful environmental impact while also being commercially viable. MissionPoint's portfolio features prominent companies like AeroFarms, a pioneer in vertical farming that focuses on sustainable food production, and Opti, which develops data-driven environmental solutions to improve water management. The firm also played a pivotal role in acquiring ImpactUs, a platform designed to facilitate private impact investments by connecting capital with impactful projects​. With an emphasis on renewable energy, food and agriculture tech, and environmental technologies, MissionPoint works to ensure its investments lead to significant climate and social benefits. The firm is particularly known for its involvement in the growth of Hannon Armstrong, a leader in sustainable infrastructure, which went public on the New York Stock Exchange in 2013​. MissionPoint has co-invested with major players such as Zouk Capital and VantagePoint Capital, aligning its capital with some of the most forward-thinking funds in the climate space​. Through its innovative approach and strategic partnerships, MissionPoint Partners continues to empower businesses that tackle pressing global issues while achieving sustainable growth.

Mistletoe, a venture capital firm based in Kanazawa, Japan, was founded by Taizo Son and Atsushi Taira in 2013. The fund focuses on early-stage investments in tech-driven startups with a strong emphasis on sustainability and social impact. Notable investments include Zipline, Playco, and Sea, reflecting their commitment to innovative and impactful ventures. Mistletoe's industry focus spans across biotechnology, clean energy, health tech, and entertainment, showing a diverse portfolio aimed at transformative technologies. Geographically, their investments are global, covering North America, Asia, and Europe, with recent activities in countries like Japan, the U.S., and Finland. Their strategy revolves around partnering with visionary founders who tackle global challenges. Mistletoe typically invests in seed to series A stages, often leading rounds with an average check size of around $2 million. They have a collaborative approach, frequently co-investing with firms like Sequoia Capital and Plug and Play Tech Center. Active in fostering an ecosystem of like-minded investors and entrepreneurs, Mistletoe values innovation and societal contributions highly. The team, including key members like Michael Kim and Satoshi Fujimura, is primarily based in Japan with a significant presence in Singapore. Startups looking to engage with Mistletoe should emphasize their mission-driven goals and innovative solutions. Approaching them through warm introductions and clear, impactful pitches increases the chances of successful engagement​.

Mithril Capital, founded in 2012 by Ajay Royan and Peter Thiel, is a venture capital firm based in Austin, Texas. The firm focuses on long-term investments across various sectors and geographies, partnering with teams that leverage technology to create lasting and valuable businesses. Mithril's investment philosophy emphasizes broadminded curiosity, capital discipline, and constructive skepticism, seeking to support industries that are ripe for technological disruption. Mithril's portfolio includes notable companies such as Helion Energy, which is pioneering fusion energy; Neocis, which is advancing robotics in dental surgery; and Glance, a rapidly growing consumer internet platform. Other significant investments include Nuvia (acquired by Qualcomm), Auris Health (acquired by Johnson & Johnson), and BlackSky, a leader in real-time geospatial intelligence. The firm prides itself on helping companies navigate critical growth inflection points, supporting them with strategic insights and substantial capital investments. This approach has enabled Mithril's portfolio companies to achieve remarkable advancements in their respective fields, from reshaping robotic surgery to revolutionizing decentralized finance and enhancing grid resilience with AI-driven energy storage solutions.

Mitsui & Co., a leading global trading and investment company, has a diverse portfolio across multiple industries. Founded in 1876 and headquartered in Tokyo, Mitsui has expanded its operations globally, focusing on sectors such as energy, healthcare, technology, and consumer goods. Notable investments by Mitsui & Co. include Lhyfe, a French company specializing in renewable green hydrogen production, aligning with Mitsui’s commitment to sustainable energy solutions. QurAlis, a biotechnology company, is developing precision medicines for ALS and other neurodegenerative diseases. Leash Biosciences is an AI-driven biotech firm revolutionizing medicinal chemistry. Kaltura, a leading video technology provider, went public through an IPO. Virident, a high-performance storage class memory solutions company, was acquired. Boston Biomedical focuses on novel cancer treatments. Proterra, a manufacturer of zero-emission vehicles, merged through a SPAC. Mitsui & Co. leverages its global network and industry expertise to support innovative companies and foster growth in various sectors.

MMC Ventures is a London-based venture capital firm that has been supporting early-stage tech entrepreneurs for over 20 years. Focused on transformative technology, MMC specializes in sectors such as artificial intelligence (AI), data-driven health, fintech, and enterprise software. The firm has built a reputation for deep industry expertise, particularly in AI and data science, where it is one of Europe's most active investors. Notable investments include Synthesia, Signal AI, and Current Health, the latter of which was acquired by Best Buy. MMC’s investment strategy is research-led, with a dedicated team of specialists who help identify and develop cutting-edge technologies. They typically invest in Seed and Series A rounds, but a significant portion of their funds is reserved for follow-on rounds, ensuring long-term support for portfolio companies. MMC also places a strong emphasis on partnering closely with founders, providing more than just capital; they offer resources like MMC Connect, a platform that facilitates introductions, coaching, and talent acquisition. In recent years, MMC has expanded its portfolio across Europe, backing companies in markets from the UK to Eastern Europe. The firm is committed to building businesses with the potential to drive technological advancements and create a positive impact on society, as evidenced by its status as one of the first B Corporations in venture capital.

Mobile Internet Capital (MIC), established in 1999, is a venture capital firm based in Japan. The firm focuses on investing in innovative technology companies with a strong emphasis on internet and mobile-related sectors. MIC has a successful track record with 22 IPOs and numerous exits. Their portfolio includes companies like Gree, a social networking service provider, and Mercari, a popular marketplace app. MIC invests in early to growth-stage companies, supporting them through multiple rounds to help them achieve significant milestones and market expansion. MIC is known for its strategic approach, leveraging its deep industry knowledge and network to provide not only capital but also valuable guidance and connections to its portfolio companies. They aim to foster long-term growth and innovation in the tech industry.

Molten Ventures, formerly known as Draper Esprit, is a leading venture capital firm based in London, with additional offices in Cambridge and Dublin. The firm focuses on investing in high-growth technology companies across Europe. Since its inception in 2006, Molten Ventures has built a diverse portfolio with significant investments in sectors like consumer technology, digital health and wellness, AI, deep tech, hardware, cloud, enterprise, and SaaS. Notable investments by Molten Ventures include Trustpilot, UiPath, Graphcore, Revolut, and Aircall. These investments highlight the firm’s emphasis on supporting innovative companies with strong potential for global impact and scalable growth. Molten Ventures typically invests from Series A onwards, providing substantial follow-on funding to support companies throughout their growth stages. Molten Ventures manages over £1.5 billion in assets and has invested in over 340 companies, making it one of the most active and influential VC firms in Europe. Their investment strategy involves combining three pools of capital—PLC, EIS, and VCT vehicles—to support a broad range of high-potential tech startups. The firm places a strong emphasis on sustainability and ESG, having integrated these principles into their investment process and company culture. Key figures at Molten Ventures include CEO Martin Davis and CFO Benjamin Wilkinson, who lead a team dedicated to identifying and nurturing transformative tech startups. The firm has also completed successful exits from companies like SportPursuit, Premfina, Conversocial, and Bright Computing.

Moment Ventures is an early-stage venture capital firm headquartered in Palo Alto, focusing on transformative technology solutions that reimagine the future of industries. The firm invests in startups at the pre-seed and seed stages, partnering with founders who are developing innovative business models and solutions to improve how industries operate. Moment Ventures is particularly focused on sectors that are evolving due to technology, such as logistics, education, e-commerce, software, and the future of work. Moment Ventures’ investment strategy revolves around leading financings and often taking board seats or observer roles to support their portfolio companies. Their investments are thematically centered on "Business at the Speed of Software," "Future of Workers," and "Masters of the Machines." This focus allows them to back founders who are creating technology that enhances productivity and efficiency across industries. Founded by Ammar Hanafi and Clint Chao in 2015, the firm leverages deep domain expertise from years of venture capital and operating experience to guide their portfolio companies through early-stage challenges. Notable exits from their portfolio include companies like Payable (acquired by Stripe) and Twin Prime (acquired by Salesforce), highlighting their ability to nurture successful startups. Moment Ventures remains dedicated to its mission of supporting early-stage entrepreneurs who are fundamentally changing industries and empowering workers to succeed in the evolving economy. They believe in building strong partnerships with founders, offering not just capital but strategic insight to ensure long-term success.

Montage Ventures, headquartered in Menlo Park, California, is an early-stage venture capital firm that focuses on investments in the fintech, e-commerce, and healthcare sectors. The firm is renowned for backing innovative startups that challenge the status quo, including notable companies like MoneyLion, a digital bank aimed at the middle class, and PeerStreet, a tech-enabled real estate investment platform. Montage Ventures typically invests in the gap between Angel and Series A rounds, with an average investment size around $2M. They are involved in 7-12 deals per year, preferring to co-invest alongside other venture firms rather than leading rounds. The fund is particularly active in the United States, with significant investments in both the East and West Coasts. The firm’s strategy emphasizes supporting technical founders with deep industry knowledge and scalable solutions. Montage Ventures looks for startups with clear market demand and strong potential for growth. They prefer warm introductions and value detailed pitch decks that outline a clear business model and growth strategy. Startups looking to connect with Montage Ventures should demonstrate a robust product-market fit and innovative solutions within fintech, e-commerce, or healthcare. Their proactive and collaborative approach makes them a preferred partner for early-stage companies aiming for transformative impact.